Make a tabular form of all bacteriology and virolgy including all disease culture media lab diagnosis pathogenesis clinical feature in tabular form
| Organism | Disease | Culture Media | Lab Diagnosis | Pathogenesis | Clinical Features |
|---|---|---|---|---|---|
| Staphylococcus aureus | Furunculosis, carbuncles, impetigo, osteomyelitis, septic arthritis, endocarditis, pneumonia, food poisoning, TSS, SSSS | Blood agar (golden-yellow colonies), Mannitol Salt Agar (MSA - yellow halo), Chapman medium | Gram +ve cocci in clusters; catalase +ve, coagulase +ve, DNase +ve; beta-hemolysis on blood agar; tube coagulase test gold standard; MRSA: oxacillin/cefoxitin resistance | Protein A (anti-opsonin), PVL toxin (leukocidin), alpha toxin (pore-forming), TSST-1 (superantigen), exfoliatin (ETA/ETB - cleaves desmoglein-1), enterotoxins (heat-stable), coagulase (fibrin clot protection) | Furuncles/carbuncles (S. aureus #1 cause), impetigo, cellulitis; food poisoning: vomiting 1-6h (preformed toxin); TSS: high fever + rash + multi-organ failure; SSSS: superficial blistering in neonates |
| Staphylococcus epidermidis | Prosthetic valve endocarditis, prosthetic joint infection, catheter-related bloodstream infection, UTI in neonates | Blood agar (white/grey colonies), Novobiocin sensitive | Coagulase -ve, catalase +ve, Novobiocin sensitive (distinguishes from S. saprophyticus); biofilm formation | Biofilm on prosthetic devices (polysaccharide intercellular adhesin - PIA), slime production; SLIME factor resists phagocytosis | Indolent infection on prosthetics, catheter infections; frequently contaminant vs. true pathogen in blood cultures |
| Staphylococcus saprophyticus | UTI in young sexually active women | Blood agar | Coagulase -ve, catalase +ve, Novobiocin RESISTANT (key differentiator) | Adhesins to uroepithelium; urease production | Dysuria, frequency, pyuria; second most common UTI in young women after E. coli |
| Streptococcus pyogenes (Group A Strep) | Pharyngitis, scarlet fever, impetigo, erysipelas, cellulitis, necrotizing fasciitis, rheumatic fever, PSGN | Blood agar (large beta-hemolytic colonies), Bacitracin sensitive | Gram +ve cocci in chains; catalase -ve; beta-hemolysis; bacitracin sensitive (A disk); PYR test +ve; ASO titer elevated post-infection | M protein (anti-phagocytic), hyaluronidase (spreading factor), streptokinase (dissolves clots), streptolysin O (ASO Ab), streptolysin S (beta-hemolysis on blood agar), SPE (erythrogenic toxin - scarlet fever, superantigen), DNase | Exudative pharyngitis (tonsillar exudates); scarlet fever (strawberry tongue, sandpaper rash, Pastia lines); rheumatic fever (Jones criteria - carditis, migratory arthritis, chorea, subcutaneous nodules, erythema marginatum); PSGN |
| Streptococcus agalactiae (Group B Strep) | Neonatal meningitis, neonatal sepsis (early/late onset), UTI in pregnancy | Blood agar (beta-hemolytic) | CAMP test +ve (arrow-shaped zone of hemolysis with S. aureus), hippurate hydrolysis +ve; bacitracin resistant; group B antigen | Polysaccharide capsule (anti-phagocytic), beta-hemolysin, CAMP factor | Early-onset neonatal disease (< 7 days): sepsis, pneumonia, meningitis (from vertical transmission); late-onset (7 days-3 months): meningitis; screen pregnant women at 35-37 weeks |
| Streptococcus pneumoniae | Lobar pneumonia (#1 cause community-acquired), meningitis, otitis media, sinusitis, bacteremia | Blood agar (alpha-hemolysis, draughtsman/checker-board colonies), Chocolate agar | Lancet-shaped diplococci; alpha-hemolysis; bile solubility +ve; Optochin sensitive; Quellung reaction (capsular swelling); Quinine sensitivity | IgA protease (destroys mucosal defense), polysaccharide capsule (>90 serotypes - major virulence), pneumolysin (cytolysin), teichoic acid (C-substance activates complement) | Rust-colored sputum, high fever, pleuritic chest pain (pneumonia); sudden onset meningitis with petechiae; #1 cause otitis media in children |
| Streptococcus viridans group (S. mutans, S. mitis, S. sanguinis) | Subacute bacterial endocarditis (SBE), dental caries | Blood agar (alpha-hemolytic) | Alpha-hemolysis; Optochin RESISTANT; bile insoluble | Dextran production (S. mutans - dental plaque biofilm, binds fibronectin on heart valves), glucan formation | Dental procedures → transient bacteremia → infects damaged heart valves; dental caries from lactic acid production |
| Enterococcus faecalis / faecium | UTI, endocarditis, wound infections, meningitis (neonates) | Blood agar, bile-esculin agar (black colonies), 6.5% NaCl broth (growth) | Gram +ve cocci pairs/short chains; catalase -ve; gamma (non-hemolytic) or alpha; PYR +ve; grows in 6.5% NaCl; hydrolyzes esculin in presence of bile; Group D antigen | Resistant to multiple antibiotics (VRE); aggregation substance (facilitates plasmid transfer and biofilm); gelatinase | UTI (second most common nosocomial); endocarditis (requires high-dose ampicillin + aminoglycoside synergy) |
| Organism | Disease | Culture Media | Lab Diagnosis | Pathogenesis | Clinical Features |
|---|---|---|---|---|---|
| Bacillus anthracis | Anthrax (cutaneous, pulmonary, GI, meningeal) | Blood agar (non-hemolytic, "Medusa head" colonies), Bicarbonate agar (capsule formation) | Large Gram +ve non-motile bacilli in bamboo-cane chains; spore forming (central spore); encapsulated; non-hemolytic; "string of pearls" on penicillin agar; CAMP test -ve | Poly-D-glutamic acid capsule (anti-phagocytic); anthrax toxin = Protective Antigen (PA) + Edema Factor (EF - adenylate cyclase → ↑cAMP) + Lethal Factor (LF - metalloprotease - kills macrophages) | Cutaneous: black eschar (painless) with edema - malignant pustule; Inhalation (Woolsorters disease): biphasic illness - flu-like then hemorrhagic mediastinitis, widened mediastinum on CXR; GI: bloody diarrhea |
| Bacillus cereus | Food poisoning (emetic/diarrheal), eye infections | Blood agar (beta-hemolytic); lecithinase +ve on egg yolk agar | Large Gram +ve motile bacilli; spore-forming; beta-hemolytic; lecithinase +ve | Emetic toxin (cereulide - heat stable, preformed) from rice/starchy foods; Enterotoxin (heat labile, diarrheal form) from meat/vegetables | Emetic form: vomiting 1-6h after reheated rice; Diarrheal form: diarrhea 8-16h; Ocular: post-traumatic panophthalmitis (very rapid, devastating) |
| Clostridium perfringens | Gas gangrene (myonecrosis), food poisoning, necrotizing enterocolitis, clostridial cellulitis | Blood agar (double zone of hemolysis - inner theta toxin, outer alpha toxin), Egg yolk agar (Nagler reaction - opacity from alpha toxin lecithinase) | Large Gram +ve boxcar-shaped bacilli with subterminal spore; anaerobic; non-motile; "stormy fermentation" of milk; Nagler reaction +ve | Alpha toxin (lecithinase C - hydrolyzes phospholipids → cell membrane destruction, hemolysis); theta toxin (perfringolysin); enterotoxin (food poisoning); kappa toxin (collagenase) | Gas gangrene: rapidly spreading, crepitant, malodorous wound; tissue gas on X-ray; food poisoning: profuse watery diarrhea 8-24h after meat; no vomiting |
| Clostridium tetani | Tetanus | Blood agar (swarming, beta-hemolytic), RCM broth | Gram +ve slender bacillus, "drumstick" appearance (terminal spore); motile (swarming); anaerobic; in-vitro toxin not well demonstrated | Tetanospasmin (neurotoxin): cleaves synaptobrevin (VAMP) in inhibitory interneurons (Renshaw cells) in spinal cord → blocks GABA and glycine release → unopposed excitation → spastic paralysis; spreads retrograde via motor neurons | Risus sardonicus (facial spasm), trismus (lockjaw), opisthotonus, autonomic instability; incubation 4-21 days; umbilical stump in neonates (neonatal tetanus - lockjaw) |
| Clostridium botulinum | Botulism (foodborne, wound, infant/intestinal, iatrogenic) | Blood agar, anaerobic | Gram +ve bacillus with oval subterminal spore; anaerobic; motile; produces neurotoxin types A-G; mouse bioassay neutralization | Botulinum toxin: cleaves SNARE proteins (VAMP/synaptobrevin for types B,D,F,G; SNAP-25 for types A,C,E) at NMJ → blocks Ach release → flaccid paralysis (descending); most potent known toxin | Foodborne: descending paralysis, diplopia, dysarthria, dysphagia (4 Ds), no fever; Infant botulism (#1 form in US): floppy baby, constipation, poor feeding (honey ingestion) |
| Clostridium difficile | Pseudomembranous colitis, antibiotic-associated diarrhea, toxic megacolon | CCFA (cycloserine-cefoxitin-fructose agar) - yellow colonies; Blood agar | Gram +ve bacillus, large; anaerobic; subterminal spore; "horse barn" odor; Toxin A (enterotoxin) and Toxin B (cytotoxin) by ELISA/PCR; GDH antigen; nucleic acid amplification test (NAAT) most sensitive | Toxin A: enterotoxin → fluid secretion, mucosal damage; Toxin B: cytotoxin → inactivates Rho GTPase → actin cytoskeleton disruption → cell death; Binary toxin (CDT) in hypervirulent BI/NAP1/027 strain; spores resist alcohol hand gels | Watery to bloody diarrhea after antibiotic use (especially clindamycin, fluoroquinolones, cephalosporins); fever; leukocytosis; pseudomembranes on colonoscopy; colonic thickening on CT |
| Corynebacterium diphtheriae | Diphtheria | Loeffler's serum slope (rapid growth), Tellurite agar (black colonies - potassium tellurite selective), Blood agar | Club-shaped Gram +ve bacilli; Chinese letter/palisade arrangement; metachromatic granules (Babes-Ernst/volutin granules) on Albert's stain (green-blue); Elek test (immunodiffusion for toxin); Albert's stain | Diphtheria toxin (encoded by beta-phage): A-B toxin; B fragment binds heparin-binding EGF receptor; A fragment = ADP ribosyltransferase → inactivates EF-2 (elongation factor 2) → halts protein synthesis → cell death; "pseudomembrane" | Pseudomembrane in throat (grayish-white, bleeds when removed, "bull neck"), hoarseness, "barking cough"; Myocarditis (heart block); Neuropathy (palate, eye muscles, peripheral); Cutaneous diphtheria |
| Listeria monocytogenes | Listeriosis (meningitis, septicemia, neonatal meningitis, gastroenteritis) | Blood agar (narrow beta-hemolysis), Brain Heart Infusion broth (grows at 4°C - cold enrichment), PALCAM/Oxford agar | Gram +ve short bacilli/coccobacilli; tumbling motility at 25°C; CAMP test +ve (S. aureus); catalase +ve; esculin hydrolysis +ve; cold enrichment at 4°C; umbrella motility in semisolid media | Internalins (InlA, InlB) → E-cadherin binding → host cell invasion; Listeriolysin O (LLO) + Phospholipases (PlcA, PlcB) → phagosomal escape; ActA → actin polymerization ("actin rocket tails") → cell-to-cell spread; intracellular pathogen | Flu-like illness; meningitis in neonates, elderly, immunocompromised, pregnant; Granulomatosis infantiseptica (stillbirth/neonatal sepsis from transplacental); associated with soft cheeses, deli meats, unpasteurized dairy |
| Erysipelothrix rhusiopathiae | Erysipeloid, septicemia, endocarditis | Blood agar (alpha-hemolytic, pipe-cleaner colonies in gelatin) | Gram +ve pleomorphic bacillus; non-motile; H2S +ve on TSI; catalase -ve; "pipe cleaner" growth in gelatin (no liquefaction); occupational exposure | Neuraminidase, hyaluronidase; capsule in virulent strains | Occupational disease (fishermen, butchers, vets, farmers); violaceous erysipeloid lesion on hand/finger; rarely endocarditis; NOT Streptococcal erysipelas |
| Actinomyces israelii | Actinomycosis (cervicofacial, thoracic, abdominal, pelvic) | Brain Heart Infusion (BHI), Thioglycollate broth; slow growth (1-2 weeks), anaerobic/microaerophilic | Gram +ve branching filamentous rods; non-acid fast; "sulfur granules" (yellow granules = bacterial colonies in pus); anaerobic/microaerophilic; NOT a true fungus | Not toxin-mediated; direct tissue invasion; forms sulfur granules; sinus tract formation; resists normal antimicrobials due to thick granule walls | "Lumpy jaw" (cervicofacial most common - after dental procedure/trauma); chronic indurated swelling with sinus tracts discharging sulfur granules; pelvic actinomycosis (IUD users) |
| Nocardia asteroides | Nocardiosis (pulmonary, CNS, cutaneous, disseminated) | Blood agar, BCYE agar; slow growing | Gram +ve branching filamentous rods; weakly/partially acid fast (modified ZN - 1% H2SO4); aerobic (unlike Actinomyces) | Catalase and SOD production → survives in phagolysosomes; inhibits phagosome-lysosome fusion; | Pulmonary nocardiosis (cavitary lesion, mimics TB) in immunocompromised; brain abscess; mycetoma (Madura foot type with white grains); cutaneous lymphocutaneous form mimics sporotrichosis |
| Organism | Disease | Culture Media | Lab Diagnosis | Pathogenesis | Clinical Features |
|---|---|---|---|---|---|
| Neisseria meningitidis | Meningococcal meningitis, meningococcemia, Waterhouse-Friderichsen syndrome | Chocolate agar, Thayer-Martin (VCN medium - vancomycin, colistin, nystatin) | Gram -ve diplococci (coffee bean shape); oxidase +ve; ferments glucose AND maltose; latex agglutination for antigen; PCR; CSF Gram stain; polysaccharide capsule serogroups A,B,C,W135,Y | Polysaccharide capsule (serogroups - major virulence); LPS endotoxin (septic shock); IgA protease; outer membrane proteins; pili (colonization of nasopharynx) | Sudden onset fever, headache, neck stiffness, photophobia, petechial/purpuric rash (non-blanching); fulminant meningococcemia (DIC, bilateral adrenal hemorrhage = Waterhouse-Friderichsen syndrome, purpura fulminans) |
| Neisseria gonorrhoeae | Gonorrhea, PID, neonatal ophthalmia, DGI, urethritis, cervicitis, epididymo-orchitis | Thayer-Martin (chocolate agar + VCN), New York City medium, modified Thayer-Martin | Gram -ve intracellular diplococci (in PMNs); oxidase +ve; ferments glucose ONLY (not maltose); no capsule; oxidase +ve; culture on Thayer-Martin; NAAT (most sensitive for urine/swab) | Pili (attachment, anti-phagocytic), Opa proteins (opacity proteins - invasion), IgA protease, LOS (lipooligosaccharide), beta-lactamase plasmids; Phase variation of pili | Urethritis (purulent discharge, dysuria); cervicitis (mucopurulent); PID (salpingitis, tubo-ovarian abscess, perihepatitis = Fitz-Hugh-Curtis); DGI: septic arthritis (knee/wrist) + dermatitis; neonatal conjunctivitis (silver nitrate prophylaxis → now erythromycin) |
| Moraxella catarrhalis | Otitis media, sinusitis, COPD exacerbation, pneumonia | Blood agar (hockey puck colonies that slide intact), Chocolate agar | Gram -ve diplococci; oxidase +ve; DNase +ve; "hockey puck" sign on blood agar; beta-lactamase +ve (most strains) | Beta-lactamase production; adherence to respiratory epithelium; IgA protease; LOS | Otitis media (3rd most common after S. pneumoniae and H. influenzae); LRTI exacerbation in COPD; hockey puck test |
| Organism | Disease | Culture Media | Lab Diagnosis | Pathogenesis | Clinical Features |
|---|---|---|---|---|---|
| Escherichia coli (ETEC, EPEC, EHEC, EIEC, EAEC) | UTI, meningitis (neonates), traveler's diarrhea, HUS, dysentery, pneumonia (nosocomial) | MacConkey agar (PINK lactose-fermenting colonies), EMB agar (metallic green sheen), SMAC (sorbitol MacConkey - O157:H7 colorless) | Gram -ve rod; lactose fermenter; IMViC: ++--(indole+, methyl red+, VP-, citrate-); motile; O,H,K antigens; NAAT for pathotypes; Shiga toxin assay | ETEC: LT (↑cAMP, like cholera) + ST (↑cGMP); EPEC: attaching-effacing; EHEC (O157:H7): Shiga toxin 1&2 (SLT - inhibits 60S ribosome); EIEC: Shigella-like plasmid invasion; meningitis K1 capsule | UTI (most common cause); ETEC: watery traveler's diarrhea; EHEC: bloody diarrhea + HUS (microangiopathic hemolytic anemia + thrombocytopenia + renal failure); K1 = neonatal meningitis |
| Klebsiella pneumoniae | Lobar pneumonia (alcoholics/diabetics), UTI, liver abscess, nosocomial infections | MacConkey agar (large mucoid pink colonies), Blood agar (mucoid) | Gram -ve rod; lactose fermenter; non-motile; urease +ve; large mucoid capsule; IMViC: --++ (indole-, methyl red-, VP+, citrate+); string test +ve (mucoviscosity) | Polysaccharide capsule (K antigen - anti-phagocytic); siderophores (aerobactin); mucoviscosity; adhesins; hypermucoviscous strains cause liver abscess | Classic: "current jelly sputum" (blood-stained mucoid), upper lobe consolidation; ESBL/CRE producing (nosocomial); Liver abscess (K1 hypervirulent - Asian populations); Friedlander pneumonia |
| Salmonella typhi | Typhoid fever (enteric fever), septicemia | MacConkey agar (colorless, non-lactose fermenting), XLD agar (red with black center - H2S), Selenite F broth (enrichment), Deoxycholate citrate agar (DCA), Wilson Blair bismuth sulphite agar (black metallic sheen) | Gram -ve rod; non-lactose fermenter; H2S +ve (except S. typhi which is variable); motile; TSI: K/A + H2S; Widal test (agglutination - TO and TH antibody titers); blood culture (week 1), urine/stool (week 2+); Vi antigen (serogrouping) | Vi capsular antigen (anti-phagocytic, blocks complement); LPS endotoxin; typhoid toxin (AB5 toxin, intracellularly activated); intracellular survival in macrophages; systemic spread | Week 1: step-ladder fever, bradycardia, rose spots on abdomen; Week 2-3: hepatosplenomegaly, intestinal hemorrhage/perforation (most serious complication); Peyer's patch involvement; carrier state (gallbladder) |
| Salmonella enteritidis/typhimurium | Salmonella gastroenteritis (non-typhoidal) | XLD, SS (Salmonella-Shigella) agar, Selenite F broth enrichment, Brilliant green agar | Non-lactose fermenter; H2S +ve; motile; TSI: K/A + H2S + gas | Invasion of intestinal epithelium; SPI-1 (Salmonella Pathogenicity Island): type III secretion → triggers macropinocytosis; inflammatory enteritis; SPI-2: intracellular survival | Diarrhea (often bloody), vomiting, fever, cramps 12-72h after poultry/eggs; self-limiting in immunocompetent; bacteremia in sickle cell patients |
| Shigella (dysenteriae, flexneri, boydii, sonnei) | Bacillary dysentery (shigellosis) | MacConkey agar (colorless), XLD agar (red colonies - no black center), SS agar, Selenite F (NOT for Shigella - inhibits it) | Non-lactose fermenter; non-motile; H2S -ve; TSI: K/A, no gas, no H2S; IMViC: +-+- (for sonnei); serotyping by Kauffmann-White | Shiga toxin (S. dysenteriae type 1 - same as Stx1 of EHEC): inhibits 60S ribosome; plasmid-mediated invasion of colonic epithelial cells; cell-to-cell spread (actin rockets, like Listeria); invasion plasmid antigen (Ipa proteins) | Profuse watery diarrhea → bloody mucoid diarrhea (dysentery); tenesmus; high fever; HUS (S. dysenteriae); Reiter syndrome (reactive arthritis after S. flexneri); very low infectious dose (10 organisms) |
| Vibrio cholerae | Cholera ("rice water stools") | TCBS agar (Thiosulfate-Citrate-Bile-Sucrose - yellow sucrose-fermenting colonies for O1/O139), Alkaline Peptone Water (APW) - enrichment, Monsur's tellurite taurocholate gelatin agar (TTGA) | Gram -ve curved rod (comma-shaped); oxidase +ve; motile with single polar flagellum; dark field microscopy "shooting star"; string test +ve; Vibrio cholerae O1 (El Tor or classical biotype) or O139 | Cholera toxin (CT): B subunit binds GM1 ganglioside; A subunit ADP-ribosylates Gs alpha → permanent adenylate cyclase activation → ↑cAMP → CFTR opens → massive Cl- secretion → water/electrolyte loss; TCP pili (colonization, phage receptor); encoded by CTX phage | Profuse painless watery "rice-water" diarrhea (no blood), vomiting; rapid dehydration; sunken eyes, "washer-woman's hands"; muscle cramps; hypotension; death from dehydration; no fever typically |
| Vibrio parahemolyticus | Gastroenteritis (seafood), wound infections | TCBS agar (GREEN blue-green colonies - sucrose non-fermenting) | Gram -ve curved rod; oxidase +ve; halophilic (requires NaCl); Kanagawa phenomenon +ve (urease +ve hemolysin on Wagatsuma agar) | Thermostable direct hemolysin (TDH - Kanagawa factor); type III secretion system | Acute watery diarrhea after raw/undercooked seafood; 4-96h incubation; wound infections in coastal waters |
| Helicobacter pylori | Peptic ulcer disease, gastric carcinoma, MALT lymphoma, gastritis | Skirrow's medium (chocolate agar + antibiotics), Campylobacter blood agar | Gram -ve curved/spiral rod with multiple polar flagella; microaerophilic; urease +ve (CLO test, urea breath test, stool antigen); silver stain (Warthin-Starry), Giemsa for histology | Urease (produces ammonia → neutralizes gastric acid); VacA (vacuolating cytotoxin → epithelial damage); CagA (oncoprotein - cancer risk); BabA adhesin; LPS; flagella (motility through mucus) | Chronic gastritis (antrum); duodenal ulcer (#1 - acid hypersecretion from antral infection suppressing somatostatin); gastric ulcer; gastric adenocarcinoma; MALT lymphoma |
| Campylobacter jejuni | Gastroenteritis (most common bacterial in developed world), reactive arthritis, Guillain-Barre syndrome | Campylobacter agar (Skirrow's), Butzler medium; microaerophilic (5% O2, 10% CO2); 42°C (not 37°C) | Gram -ve slender curved/S-shaped "gull-wing" rod; oxidase +ve; hippurate hydrolysis +ve (C. jejuni vs. coli); motile with corkscrew darting motility | Flagella (motility, invasion), CDT (cytolethal distending toxin), LOS molecular mimicry of gangliosides → Guillain-Barre (ascending flaccid paralysis); jejunum/ileum invasion | Bloody diarrhea, fever, cramping 2-5 days after poultry/contaminated water; self-limiting; GBS (ascending flaccid paralysis) 2-4 weeks post-infection (anti-ganglioside antibodies); Reiter syndrome |
| Yersinia pestis | Plague (bubonic, pneumonic, septicemic) | Blood agar (gray colonies), MacConkey agar; grows at 28°C better than 37°C | Gram -ve coccobacillus; "safety-pin" appearance on Wayson/bipolar stain; non-motile at 37°C, motile at 22°C; F1 antigen (diagnostic); biphasic growth optimum | F1 capsular antigen (anti-phagocytic); LPS (low immunogenicity); Yops (Yersinia outer proteins - type III secretion - anti-phagocytic); Plasminogen activator (Pla protease - dissemination); siderophore (iron acquisition) | Bubonic plague: painful swollen lymph nodes (buboes - inguinal/axillary) after flea bite; Pneumonic plague: rapidly fatal pneumonia (droplet transmission - most dangerous); Septicemic plague: DIC, black gangrenous patches ("Black Death") |
| Yersinia enterocolitica | Gastroenteritis, mesenteric lymphadenitis (pseudoappendicitis), reactive arthritis | MacConkey agar (lactose non-fermenter), CIN agar (Cefsulodin-Irgasan-Novobiocin - bull's-eye colonies) | Gram -ve rod; urease +ve; motile at 25°C, non-motile at 37°C; CIN agar bull's eye; cold enrichment at 4°C | Type III secretion (Yops); iron chelation enhanced by hemochromatosis (special risk); YadA adhesin | Diarrhea, fever, abdominal pain (mimics appendicitis - right lower quadrant pain - mesenteric lymphadenitis); reactive arthritis, thyroiditis (autoimmune cross-reaction) |
| Proteus mirabilis | UTI, urinary stones (struvite), wound infections | MacConkey agar (colorless), Blood agar (swarming, fishy odor) | Gram -ve rod; urease strongly +ve; swarming motility; non-lactose fermenter; Weil-Felix test (OX19, OX2, OXK agglutination - for rickettsial diseases); H2S +ve | Urease (splits urea → NH3 + CO2 → raises urine pH → struvite stone formation); swarming motility (MR/P fimbriae); iron acquisition | UTI with staghorn calculi; alkaline urine (pH >8); "fishy" or "popcorn" odor colonies; associated with catheter-associated UTI |
| Pseudomonas aeruginosa | Pneumonia (CF patients, ventilator-associated), burn wound infections, UTI (nosocomial), otitis externa, folliculitis, septicemia | MacConkey (colorless), Blood agar (grape-like odor, beta-hemolytic), King A medium (pyocyanin - blue-green), King B medium (pyoverdin - yellow-green fluorescent) | Gram -ve rod; oxidase +ve; non-lactose fermenter; produces pyocyanin (blue-green pigment), pyoverdin (green fluorescent); fruity/grape-like odor; non-glucose-fermenting | Exotoxin A (ADP-ribosylates EF-2, like diphtheria toxin); LPS; alginate (biofilm in CF); elastase (LasB - destroys elastin); exoenzymes (ExoS,T,U,Y - type III); siderophores; flagella; pili; quorum sensing | Hot tub folliculitis; "blue-green pus"; otitis externa (swimmer's ear); ecthyma gangrenosum (black necrotic lesions in immunocompromised); CF lung disease (mucoid strains); burn wound superinfection |
| Organism | Disease | Culture Media | Lab Diagnosis | Pathogenesis | Clinical Features |
|---|---|---|---|---|---|
| Haemophilus influenzae | Meningitis (children pre-vaccine), epiglottitis, pneumonia, otitis media, septic arthritis | Chocolate agar; requires X factor (hemin) and V factor (NAD); satellite phenomenon (grows near S. aureus on blood agar) | Gram -ve coccobacillus; X+V factor requirement; satellite growth; capsule type b (Hib) = polyribosyl ribitol phosphate (PRP) antigen; Quellung reaction; IgA protease | Polysaccharide capsule type b (anti-phagocytic, PRP); IgA protease; LPS; outer membrane proteins; non-typeable strains lack capsule | Hib: meningitis (children 6mo-2yr), acute epiglottitis ("cherry-red thumb sign" on lateral neck X-ray, drooling, tripod position); NTHi: otitis media, sinusitis, COPD exacerbation |
| Bordetella pertussis | Whooping cough (pertussis) | Bordet-Gengou agar (BG medium - potato-blood-glycerol - "mercury drop" colonies), Regan-Lowe charcoal agar | Small Gram -ve coccobacillus; non-motile; DFA (direct fluorescent antibody); PCR (most sensitive); serology (anti-PT IgA) | Pertussis toxin (PT - A-B toxin - ADP-ribosylates Gi → ↑cAMP → lymphocytosis, insulin secretion, histamine sensitization); filamentous hemagglutinin (FHA - adhesin); tracheal cytotoxin; adenylate cyclase toxin (ACT - pore-forming, ↑cAMP); LPS | Catarrhal stage (1-2w): cold-like; Paroxysmal stage (2-6w): paroxysmal cough + inspiratory "whoop" + posttussive vomiting + cyanosis; Convalescent stage; lymphocytosis; young infants: apnea without whoop |
| Legionella pneumophila | Legionnaires disease (atypical pneumonia), Pontiac fever | BCYE-alpha agar (Buffered Charcoal Yeast Extract - requires L-cysteine and Fe); will NOT grow on ordinary blood agar | Gram -ve bacillus (poorly Gram-staining - needs silver stain or Dieterle stain); Urinary antigen test (most rapid, L. pneumophila serogroup 1); DFA; PCR; intracellular in amoebae | Dot/Icm type IV secretion system → prevents phagosome-lysosome fusion → intracellular replication in macrophages/monocytes; LPS (unusual structure); siderophores; flagella; Mip (metalloprotease) | Legionnaires disease: severe pneumonia + hyponatremia + diarrhea + confusion (extrapulmonary clues); relative bradycardia; ↑LDH; associated with water cooling towers, hot tubs; Pontiac fever: self-limiting flu-like illness |
| Brucella (abortus, melitensis, suis, canis) | Brucellosis (undulant fever), osteomyelitis, orchitis | Blood agar, Brucella agar; slow growing (2-6 weeks); CO2 required for B. abortus | Gram -ve small coccobacillus; non-motile; urease +ve (B. suis, melitensis); Standard tube agglutination test (STAT); 2-mercaptoethanol test (IgG vs. IgM differentiation); oxidase +ve | Survives intracellularly in macrophages (inhibits phagosome-lysosome fusion); LPS (smooth LPS virulence - rough strains avirulent); erythritol (reproductive tissue tropism - erythritol in placenta → abortion); cyclic beta-1,2 glucans | Undulant (relapsing) fever, night sweats, arthralgia, hepatosplenomegaly; spondylitis (vertebral osteomyelitis - Pott's disease ddx); orchitis/epididymitis; endocarditis; spontaneous abortion in cattle; occupational disease (vets, farmers, abattoir workers) |
| Francisella tularensis | Tularemia (rabbit fever, deerfly fever) | Glucose-cysteine blood agar, BCYE; biosafety level 3 | Gram -ve small coccobacillus; non-motile; difficult to culture; requires cysteine; serological tests; PCR; DFA | Intracellular pathogen (survives in macrophages, inhibits phagosome acidification); LPS (less immunostimulatory); polysaccharide capsule | Ulceroglandular (most common - tick/deerfly bite → ulcer + lymphadenopathy); Typhoidal (bacteremia, most severe); Pneumonic; Oculoglandular; Oropharyngeal; very low infectious dose (10 organisms) |
| Pasteurella multocida | Wound infections (animal bite/scratch), cellulitis, septicemia, pneumonia | Blood agar (smooth, non-hemolytic), MacConkey (colorless) | Gram -ve coccobacillus; bipolar staining ("closed safety pin"); oxidase +ve; catalase +ve; indole +ve; non-lactose fermenter; no growth on MacConkey (some strains) | Capsule (types A-F; type A - LPS); outer membrane proteins; LPS | Rapidly progressing cellulitis after dog/cat bite or scratch (develops within 24h - faster than usual wound infection); septic arthritis; bacteremia in liver disease patients |
| Bartonella henselae | Cat scratch disease, bacillary angiomatosis, bacteremia | Chocolate agar, BCYE (very slow - up to 6 weeks); intracellular | Gram -ve small curved bacilli; difficult to culture; Warthin-Starry silver stain (in tissue); IFA serology; PCR; Parinaud oculoglandular syndrome | Pili (adhesins); BadA (adhesin); LPS; intracellular replication in endothelial cells (bacillary angiomatosis) and macrophages | Cat scratch disease: papule at inoculation site → tender regional lymphadenopathy (axillary most common); Parinaud oculoglandular syndrome; Bacillary angiomatosis (AIDS patients): vascular proliferative lesions mimicking Kaposi sarcoma |
| Organism | Disease | Culture Media | Lab Diagnosis | Pathogenesis | Clinical Features |
|---|---|---|---|---|---|
| Treponema pallidum | Syphilis (primary, secondary, tertiary, congenital), bejel, yaws, pinta | Cannot be cultured in vitro (requires live tissue/rabbit testes - Sheffield medium - experimental) | Dark field microscopy (primary/secondary chancre); FTA-ABS (most sensitive/specific - treponemal test); VDRL/RPR (non-treponemal - screening, titer follows treatment); TP-PA; IgM FTA-ABS (congenital) | Hyaluronidase (tissue spread); outer membrane proteins (Tproteins); immune evasion by outer membrane variation; evades phagocytosis; spirochetal motility (corkscrew) | Primary: painless indurated chancre + painless lymphadenopathy; Secondary: maculopapular rash on palms/soles, condyloma lata, mucous patches, generalized lymphadenopathy; Latent; Tertiary: gummas, aortitis (aortic regurgitation), neurosyphilis (tabes dorsalis, Argyll Robertson pupil) |
| Borrelia burgdorferi | Lyme disease | BSK (Barbour-Stoenner-Kelly) medium; very slow growing | Silver stain; serology ELISA (screening) + Western blot (confirmation); two-tier testing; PCR; clinical diagnosis (erythema migrans) | OspC (outer surface protein - early infection); VlsE (antigenic variation in joints/CNS); inhibits complement; persists in extracellular matrix; spirochetal motility | Stage 1: Erythema migrans (bull's eye rash, >5cm); Stage 2 (disseminated): Lyme carditis (AV block), Lyme neuroborreliosis (Bell palsy, meningitis, radiculopathy); Stage 3 (late): Lyme arthritis (large joint, especially knee), encephalopathy |
| Borrelia recurrentis/hermsii | Relapsing fever (epidemic/endemic) | KELLY medium, blood smear | Giemsa/Wright stain of peripheral blood smear (spirochetes visible during febrile episode); Variable major proteins (VMP) | Antigenic variation of VMP (major mechanism of relapse - new serotype outruns immune response each relapse) | Episodic fever (febrile 3-7 days → afebrile → febrile again); hepatosplenomegaly; jaundice; Louse-borne (B. recurrentis - epidemic); Tick-borne (B. hermsii/duttonii - endemic) |
| Leptospira interrogans | Leptospirosis (Weil disease, rat fever) | EMJH medium (Ellinghausen-McCullough-Johnson-Harris), Fletcher's semi-solid medium; 30°C; 6-8 weeks | Dark field microscopy; Silver stain; MAT (Microscopic Agglutination Test) - gold standard serology; PCR (early); urine culture (2nd week) | Outer membrane lipoproteins (LipL32 - major); LPS (serovar-specific); motility; sphingomyelinase; hemolysins; tissue invasion; Kidney and liver tropism | Biphasic illness: Leptospiremic phase (4-7 days): fever, headache, myalgia (calf muscle tenderness), conjunctival suffusion; Immune phase (Weil disease): jaundice, renal failure (acute tubular necrosis), hemorrhage, uveitis, Canicola fever |
| Organism | Disease | Culture Media | Lab Diagnosis | Pathogenesis | Clinical Features |
|---|---|---|---|---|---|
| Mycobacterium tuberculosis | Pulmonary TB, miliary TB, meningitis, lymphadenitis (scrofula), Pott's disease, renal TB, genitourinary TB | LJ (Lowenstein-Jensen) medium - rough buff "breadcrumb" colonies (6-8 weeks); Middlebrook 7H10/7H11 (faster); BACTEC 460 (radiometric, fastest liquid culture) | Acid-fast bacilli (ZN stain - red bacilli on blue background; Kinyoun cold ZN); fluorescence microscopy (Auramine-rhodamine stain - most sensitive for smear); Mantoux/TST; IGRA (QuantiFERON/T-SPOT); PCR (Xpert MTB/RIF); cord formation (serpentine cords) | Cord factor (trehalose-6,6'-dimycolate - inhibits PMN migration, mitochondrial toxicity); LAM (lipoarabinomannan - inhibits IFN-γ signaling, TNF-α, phagosome maturation); sulfolipids (inhibit phagolysosome fusion); intracellular survival in macrophages; granuloma formation (caseous necrosis) | Primary TB: usually asymptomatic, Ghon focus (lower lobe), Ghon complex (+ hilar lymph nodes); Reactivation TB: upper lobe cavitation, night sweats, hemoptysis, weight loss; Miliary TB (hematogenous spread): millet seed shadows on CXR; Pott's disease: vertebral collapse; meningitis |
| M. leprae | Leprosy (tuberculoid, lepromatous, borderline) | Cannot be cultured in vitro; grows in armadillo footpads/mouse footpad; 27-30°C; doubling time 13 days | ZN stain (acid-fast, bead-like arrangement in bundles = "globi"); Wade-Fite stain; Lepromin test (Mitsuda reaction - tuberculoid = +ve); slit skin smear (bacterial index/morphological index) | Predilection for cooler areas (skin, peripheral nerves, testes); intracellular in Schwann cells and macrophages; binds laminin-2 (alpha2 chain) in Schwann cell; triggers demyelination; ineffective cell-mediated immunity (lepromatous) | TT (tuberculoid): few hypopigmented anesthetic patches, well-defined, nerve thickening, AFB-negative; LL (lepromatous): diffuse symmetric infiltration, leonine facies, madarosis, testicular atrophy, "glove-stocking" anesthesia, AFB-positive (globi); Reactions: Type 1 (reversal) and Type 2 (ENL - erythema nodosum leprosum) |
| M. avium complex (MAC) | Disseminated infection in AIDS (CD4 <50), pulmonary disease, lymphadenitis (children) | Middlebrook 7H11, BACTEC | AFB stain; blood culture (lysis-centrifugation system); PCR; DNA probe | Low virulence; intracellular in macrophages; ubiquitous environmental organism; immunosuppression required for dissemination | Fever, night sweats, weight loss, hepatosplenomegaly, anemia, elevated ALP in AIDS patients; CD4 < 50/μL threshold; pulmonary MAC: Lady Windermere syndrome (RML/lingula) in postmenopausal thin women |
| Organism | Disease | Culture Media | Lab Diagnosis | Pathogenesis | Clinical Features |
|---|---|---|---|---|---|
| Chlamydia trachomatis | Trachoma, urethritis/cervicitis (most common bacterial STI), PID, lymphogranuloma venereum (LGV), neonatal conjunctivitis/pneumonia | McCoy cells, HeLa cells (cell culture only); Does NOT grow on agar | Obligate intracellular; 2 forms: Elementary body (EB - infectious, extracellular, metabolically inactive) and Reticulate body (RB - intracellular, replicating, metabolically active); iodine-staining intracytoplasmic inclusions; NAAT (gold standard); DFA; ELISA | EB attaches (MOMP - major outer membrane protein) → endocytosis → converts to RB (prevents phagolysosome fusion) → replication → RB converts to EB → cell lysis; triggers inflammatory response | Trachoma (serovars A-C): scarring conjunctivitis → corneal scarring → blindness (leading infectious blindness cause); STI (serovars D-K): urethritis, cervicitis, PID; LGV (serovars L1-L3): genital ulcer + inguinal lymphadenopathy (buboes, groove sign); Neonatal: inclusion conjunctivitis, afebrile pneumonia (staccato cough) |
| Chlamydophila pneumoniae | Atypical pneumonia, bronchitis | HeLa/Hep-2 cells only | Obligate intracellular; serology (MIF - microimmunofluorescence); PCR | As above; respiratory transmission (no animal reservoir - human-to-human) | Atypical pneumonia (milder than typical); pharyngitis, bronchitis; hoarseness; associated with atherosclerosis (controversial) |
| Chlamydophila psittaci | Psittacosis (ornithosis) | Cell culture only | Obligate intracellular; serology (CFT, MIF); PCR; zoonosis (birds) | As above; inhalation of bird droppings | Pneumonia with splenomegaly; exposure to parrots/pet birds (psittacine birds), poultry; relative bradycardia; hepatitis |
| Rickettsia rickettsii | Rocky Mountain Spotted Fever (RMSF) | Vero cells, embryonated eggs; BSL-3 | Obligate intracellular Gram -ve coccobacillus; Weil-Felix test (OX-19 +ve, OX-2 +ve); Immunofluorescence (gold standard); PCR; skin biopsy | Tick-borne (Dermacentor); infects endothelial cells → vasculitis; spreads cell-to-cell via actin polymerization; ↑vascular permeability; DIC | Triad: fever + headache + rash (rash starts peripherally on wrists/ankles → spreads centripetally → involves palms and soles); thrombocytopenia; "spotted but not initially spotted" (rash may be absent early) |
| Rickettsia typhi/prowazekii | Epidemic typhus (R. prowazekii - louse-borne), Endemic typhus/murine typhus (R. typhi - flea-borne) | Cell culture, embryonated eggs | Weil-Felix OX-19 +ve; IFA (gold standard) | Obligate intracellular endothelial cell invasion; vasculitis; louse-borne (body louse Pediculus) for epidemic; flea feces scratched into skin for endemic | Epidemic typhus: high fever, headache, maculopapular rash (centrifugal spread - trunk to extremities, spares face/palms/soles); "Brill-Zinsser disease" = recrudescence decades later; Endemic: milder version |
| Coxiella burnetii | Q fever (acute: pneumonia, hepatitis; chronic: endocarditis) | BSL-3 (highly infectious); Vero cells; embryonated eggs | Obligate intracellular Gram -ve bacillus (but stains poorly); Phase I antigen (chronic/endocarditis) > Phase II (acute) on serology (IFA); PCR; | Spore-like forms (extreme environmental resistance); acidophilic - replicates in phagolysosome (unlike other rickettsiae); Phase I (virulent) and Phase II (avirulent); inhalation of aerosols from placental products of livestock | Acute Q fever: atypical pneumonia (patchy infiltrates, "round pneumonia"), hepatitis (granulomatous), fever; Chronic Q fever: culture-negative endocarditis (years later); no rash typically; NO Weil-Felix reaction (key differentiator) |
| Mycoplasma pneumoniae | Atypical ("walking") pneumonia, tracheobronchitis, bullous myringitis | Eaton's medium (Diphasic medium), SP-4 medium; "fried egg" colonies; very slow (1-3 weeks) | No cell wall (Gram stain negative but not technically Gram -ve); smallest self-replicating organisms; complement fixation test; Cold agglutinins (IgM anti-I antigen - clumps RBCs at 4°C - non-specific); NAAT (most sensitive); P1 adhesin | P1 adhesin (attaches to respiratory epithelium, prevents clearance); no cell wall (inherently beta-lactam resistant); hydrogen peroxide production; community acquired pneumonia; causes autoimmune cold agglutinins (anti-I IgM) | "Walking pneumonia" (mild enough to continue daily activities); dry hacking cough; X-ray worse than clinical exam; cold agglutinins; extrapulmonary: Stevens-Johnson syndrome, bullous myringitis, hemolytic anemia, encephalitis, erythema multiforme |
| Virus | Disease | Culture/Lab | Pathogenesis | Clinical Features |
|---|---|---|---|---|
| HSV-1 (Human Herpesvirus 1) | Orolabial herpes ("cold sores"), herpetic gingivostomatitis, keratoconjunctivitis, herpetic whitlow, encephalitis (temporal lobe) | Vero cells, MRC-5 cells (multinucleated giant cells with eosinophilic Cowdry A intranuclear inclusions); DFA; PCR (CSF for encephalitis); Tzanck smear (intranuclear inclusions, giant cells) | Infects sensory neurons → latency in trigeminal ganglia → reactivation triggers; tegument protein VP16 (transactivator); viral thymidine kinase (target of acyclovir - phosphorylates acyclovir to ACV-MP); ICP34.5 (neurovirulence) | Recurrent herpes labialis (cold sores); primary herpetic gingivostomatitis (children, high fever); herpes keratitis (dendritic corneal ulcers, most common cause infectious corneal blindness in developed world); HSV encephalitis: temporal lobe hemorrhagic necrosis (most common sporadic encephalitis, RUQ seizures) |
| HSV-2 (Human Herpesvirus 2) | Genital herpes, neonatal herpes, aseptic meningitis | Vero/MRC-5; Tzanck smear; PCR (most sensitive); serology (type-specific gG antibody) | Latency in sacral ganglia (S2-S4); as above for viral thymidine kinase | Recurrent painful genital ulcers; neonatal herpes (from vaginal delivery in primary maternal infection - disseminated, CNS, or skin/eye/mouth disease); Mollaret's meningitis (recurrent aseptic) |
| VZV (HHV-3) | Varicella (chickenpox), herpes zoster (shingles), Ramsay Hunt syndrome | Embryonic lung fibroblasts; Tzanck smear (syncytia, Cowdry A inclusions); DFA; PCR | Enters via respiratory tract → viremia → skin; latency in dorsal root ganglia (all levels) and trigeminal/geniculate ganglia; reactivation when cellular immunity wanes; thymidine kinase target of acyclovir | Varicella: centripetal vesicular rash (face → trunk → extremities), crops of lesions at different stages ("dew drops on rose petal"), fever, pruritus; Complications: Reye syndrome (salicylate use in children), varicella pneumonia (adults), cerebellitis; Zoster: dermatomal vesicular rash + severe pain (postherpetic neuralgia); Ramsay Hunt: geniculate ganglion - ear vesicles + ipsilateral facial palsy + vertigo |
| EBV (HHV-4) | Infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma, primary CNS lymphoma (AIDS), EBV+ PTLD, hairy leukoplakia | B-lymphocyte transformation (immortalization in vitro); Peripheral blood smear; Monospot (heterophile antibody test - Paul-Bunnell - absorbed with guinea pig kidney); VCA IgM/IgG (acute), EA (early antigen), EBNA (nuclear antigen - late, appears after recovery); PCR | Infects B cells via CD21 (complement receptor CR2) and epithelial cells; latency (EBNA1, EBNA2, LMP1 = oncoproteins); LMP1 mimics CD40 → B cell proliferation; LMP2A mimics BCR; latency I (Burkitt), II (NPC, HD), III (IM, PTLD); EBV nuclear antigen 1 (EBNA-1) - resistant to antigen processing (GARP repeats) | IM: fever + pharyngitis + lymphadenopathy (posterior cervical) + splenomegaly (rupture risk - no contact sports) + atypical lymphocytes (Downey cells - CD8+ T cells) + heterophile Ab; Burkitt lymphoma (endemic - jaw mass, associated with Plasmodium, t(8;14) c-myc translocation); NPC (southern Chinese); Ampicillin rash (diffuse maculopapular - NOT true penicillin allergy) |
| CMV (HHV-5) | Congenital CMV (most common congenital viral infection), CMV mononucleosis, CMV retinitis (AIDS, CD4<50), pneumonitis, colitis (transplant), GI disease | Human fibroblasts (MRC-5, WI-38) - slow CPE (3-4 weeks); Shell vial assay (24-48h centrifugation, pp65 antigenemia); NAAT/PCR (viral load, gold standard monitoring); CMV-specific IgM/IgG serology; Urine/blood culture; Owl-eye intranuclear inclusions on histology | Infects all nucleated cells; pp65 (lower matrix phosphoprotein - target of antigenemia assay); latency in monocytes/granulocyte precursors; immune evasion (downregulates MHC I via US2/US11, inhibits NK via UL18); fetal infection - periventricular calcification; unique UL97 kinase (phosphorylates ganciclovir) | Congenital CMV: periventricular calcifications, microcephaly, sensorineural hearing loss, chorioretinitis, petechiae ("blueberry muffin" rash), hepatosplenomegaly (most common congenital infection, most common cause non-hereditary SNHL); CMV retinitis (AIDS): "pizza pie" appearance (hemorrhage + exudates + retinal necrosis); Transplant: CMV syndrome (fever, malaise, ↓ counts) |
| HHV-6 (Roseola virus) | Roseola infantum (Exanthem subitum, Sixth disease) | T-cell tropism; cell culture; PCR; serology | CD4+ T cell tropism (also CD134/OX40); latency in macrophages/monocytes; reactivation in transplant recipients | High fever 3-5 days → sudden fever defervescence → diffuse rose-pink maculopapular rash (Rose rash after fever - distinguishes from scarlet fever); febrile seizures; most common cause of febrile seizures; reactivation in immunocompromised |
| HHV-8 (KSHV) | Kaposi's sarcoma, primary effusion lymphoma (PEL), Multicentric Castleman disease | Cell culture; PCR; serology; IHC on biopsy | Encodes viral homologs of cellular proteins (vIL-6, vIRF, viral FLICE, vCyclin D); latency in endothelial cells; LANA-1 (latency-associated nuclear antigen) | Kaposi's sarcoma: purple violaceous lesions on skin/mucosa in AIDS (CD4<200) or in classic form (elderly Mediterranean men); PEL: body cavity lymphoma |
| Virus | Disease | Culture/Lab | Pathogenesis | Clinical Features |
|---|---|---|---|---|
| Variola virus | Smallpox (eradicated 1980) | BSL-4; embryonated eggs (Guarnieri bodies = intracytoplasmic inclusions); electron microscopy (brick-shaped virion) | Respiratory droplet transmission; replication in skin (dermal capillary endothelium); viremia; inhibits host interferon response | Centrifugal distribution (starts on face → extremities, all lesions at SAME stage); deep, umbilicated, firm lesions; high mortality (30%); last natural case 1977 |
| Monkeypox/Mpox virus | Mpox (human monkeypox) | BSL-3; PCR (gold standard); electron microscopy; cell culture | Zoonotic (rodents, not monkeys); human-to-human transmission (close contact, respiratory); cross-reacts with smallpox vaccine immunity | Fever + lymphadenopathy (distinguishes from smallpox) + centrifugal rash (synchronous lesions like smallpox, unlike VZV); genital lesions (2022 outbreak - sexual transmission, MSM); self-limiting; anorectal syndrome |
| Molluscum contagiosum | Molluscum contagiosum | Cell culture (does not grow); electron microscopy; clinical diagnosis; biopsy (Henderson-Paterson bodies = molluscum bodies = intracytoplasmic inclusions in stratum granulosum) | Direct contact; poxvirus that infects keratinocytes; encodes immunomodulatory proteins (MC148 - inhibits CC chemokines) | Dome-shaped pearly papules with central umbilication; sexually transmitted in adults (genital); atopic dermatitis patients; extensive in immunocompromised |
| Virus | Disease | Culture/Lab | Pathogenesis | Clinical Features |
|---|---|---|---|---|
| Adenovirus | Upper/lower respiratory tract infection, pharyngoconjunctival fever, epidemic keratoconjunctivitis, gastroenteritis (40,41), hemorrhagic cystitis, intussusception | HEK-293, HeLa cells (CPE: cell rounding, grape-like clusters); Shell vial; PCR; stool EM; serology; antigen detection | Non-enveloped; fiber protein (binds CAR receptor); penton base (integrin binding, endosomal escape); E1A/E1B (inactivate pRb and p53 - immortalization); VA RNA (blocks PKR - anti-interferon) | Pharyngoconjunctival fever (serotype 3,7): fever + pharyngitis + non-exudative conjunctivitis (swimming pools); EKC (serotypes 8,19,37): severe keratoconjunctivitis; Gastroenteritis (40,41): second most common viral gastroenteritis in children; Hemorrhagic cystitis (11,21) |
| Virus | Disease | Culture/Lab | Pathogenesis | Clinical Features |
|---|---|---|---|---|
| HPV (Human Papillomavirus) | Warts (verruca), condyloma, CIN/cervical cancer, oropharyngeal cancer, laryngeal papillomatosis | Cannot be cultured in standard cell lines; PCR (genotyping); Pap smear (koilocytes - perinuclear halo, wrinkled/raisinoid nuclei); colposcopy/biopsy; p16 IHC | Non-enveloped circular dsDNA; infects basal keratinocytes via micro-abrasion; E6 (degrades p53 via E6AP ubiquitin ligase); E7 (binds/inactivates pRb → ↑E2F → cell cycle progression); Low-risk (6,11 - condyloma, laryngeal papillomatosis); High-risk (16,18,31,33 - cancer) | Low-risk (6,11): condyloma acuminata (cauliflower-like genital warts), laryngeal recurrent respiratory papillomatosis (neonatal from vaginal delivery); High-risk (16,18): CIN 2/3 → cervical carcinoma (most common gynecologic cancer worldwide); HPV-16: squamous cell (oropharynx, cervix); HPV-18: adenocarcinoma cervix |
| JC virus (JCV) | Progressive multifocal leukoencephalopathy (PML) | Human fetal glial cells; PCR of CSF (diagnostic) | Infects oligodendrocytes → lytic infection → demyelination; ubiquitous seroprevalence (60-80%); reactivation in severe immunosuppression (AIDS CD4<100, natalizumab users) | PML: progressive cognitive decline, focal neurological deficits, visual field defects; white matter lesions on MRI (no mass effect, no enhancement); near-universally fatal in untreated AIDS |
| Virus | Disease | Culture/Lab | Pathogenesis | Clinical Features |
|---|---|---|---|---|
| Hepatitis B virus (HBV) | Acute hepatitis B, chronic hepatitis B, cirrhosis, hepatocellular carcinoma (HCC) | HepG2 cells (transfection); serology panel: HBsAg (surface Ag - active infection), anti-HBs (immunity), HBeAg (high replication), HBcAg (core, not in serum), anti-HBc IgM (acute), anti-HBc IgG (past/chronic), anti-HBe (seroconversion), HBV DNA (viral load); liver biopsy (ground-glass hepatocytes) | Reverse transcriptase (RNA→DNA; target of NRTIs); HBsAg = Australian antigen; HBeAg = high infectivity; Core antigen; X protein (transactivator, HCC); immune-mediated liver damage (CTL attack HBV-infected hepatocytes); precore mutant (HBeAg-negative chronic hepatitis) | Acute: jaundice, nausea, RUQ pain, elevated ALT/AST; serum sickness-like prodrome; Chronic (5-10% adults, 90% neonates): 4 phases (immune tolerant → immune active → inactive carrier → reactivation); HCC (HBsAg carriers have 100x risk); extrahepatic: polyarteritis nodosa, membranous glomerulonephritis |
| Parvovirus B19 | Fifth disease (erythema infectiosum), hydrops fetalis, aplastic crisis (sickle cell), pure red cell aplasia (immunocompromised), arthropathy | Does NOT grow in standard cell lines; PCR (gold standard); serology (IgM/IgG); Parvovirus B19 DNA by PCR | Single-stranded DNA; P antigen (globoside - receptor on RBC precursors); cytotoxic to erythroid progenitors in bone marrow; maternal viremia → transplacental → fetal anemia → hydrops fetalis | Erythema infectiosum: "slapped cheek" rash + lacy reticular body rash; by rash onset, no longer infectious; arthropathy (adults, especially women - symmetric small joints); aplastic crisis in hemolytic anemias (sickle cell, spherocytosis - temporary halt of RBC production); hydrops fetalis (fetal death) |
| Virus | Disease | Culture/Lab | Pathogenesis | Clinical Features |
|---|---|---|---|---|
| Poliovirus | Poliomyelitis (paralytic and non-paralytic), post-polio syndrome | Vero cells, primary monkey kidney cells; cytopathic effect; neutralization test; stool culture (most sensitive); PCR; AFP surveillance | Fecal-oral transmission; infects oropharynx and GI → viremia → anterior horn motor neurons (via CD155 receptor); lytic infection of lower motor neurons | Majority: asymptomatic; Minor illness: fever, sore throat; Aseptic meningitis; Paralytic polio (flaccid asymmetric paralysis + fever, no sensory loss, normal CSF protein, pleocytosis); Bulbar polio: respiratory failure |
| Coxsackievirus A | Herpangina, hand-foot-mouth disease (HFMD), acute hemorrhagic conjunctivitis | BGM cells; Vero cells; PCR (stool/throat); serology | Fecal-oral and respiratory; cytotoxic effect on target tissues; HFMD: Cox A16 (classic), EV-A71 (neurological complications) | Herpangina: fever + small painful vesicles on soft palate/uvula/tonsils; HFMD: oral ulcers + vesicles on palms/soles/buttocks; EV-A71 HFMD: rhombencephalitis, pulmonary edema |
| Coxsackievirus B | Pleurodynia (Bornholm disease), myocarditis, pericarditis, aseptic meningitis, neonatal sepsis | Suckling mouse inoculation; Vero cells; PCR | Fecal-oral; myocardial inflammation; | Pleurodynia: severe chest/abdominal wall pain ("devil's grip"); viral myocarditis (dilated cardiomyopathy); neonatal sepsis/myocarditis (severe, fatal) |
| Echovirus | Aseptic meningitis, rashes, neonatal sepsis, diarrhea | Vero cells, MRC-5; PCR | Fecal-oral; | Summer aseptic meningitis (most common cause) |
| Hepatitis A virus (HAV) | Acute viral hepatitis A (self-limiting, no chronicity) | Human hepatoma cells (FRhK-4); PCR; anti-HAV IgM (acute) + anti-HAV IgG (past/immune) | Fecal-oral; replicates in gut → viremia → liver; cytopathic effect less important, immune-mediated hepatocyte damage | Jaundice, dark urine, pale stools, elevated ALT; self-limiting; fulminant hepatitis rare; no carrier state, no chronic infection; common in developing countries, seafood, contaminated water |
| Rhinovirus | Common cold, asthma/COPD exacerbation | WI-38, MRC-5 (33°C, not 37°C); PCR | ICAM-1 receptor (major group), LDL-R (minor group); infects upper respiratory epithelium (prefers 33-35°C); no cytopathic changes until advanced | Most common cause of common cold; rhinorrhea, nasal congestion, mild sore throat, no fever typically; precipitates asthma exacerbations |
| Virus | Disease | Culture/Lab | Pathogenesis | Clinical Features |
|---|---|---|---|---|
| Norovirus (Norwalk virus) | Epidemic gastroenteritis ("cruise ship" virus, "stomach flu") | Cannot be cultured; RT-PCR (stool - gold standard); electron microscopy (calicivirus morphology); antigen detection ELISA | Binds HBGA (histoblood group antigen - Lewis b antigen on gastric epithelium); non-enveloped ssRNA; infects villous epithelial cells → malabsorption and altered secretion | Sudden onset nausea, vomiting (projectile), watery non-bloody diarrhea, cramping; 24-48h duration; low infectious dose; very contagious; all age groups; outbreaks in closed settings (ships, hospitals) |
| Rotavirus | Acute gastroenteritis (leading cause in children <5 globally) | MA-104 cells; ELISA antigen (stool) - rapid test; electron microscopy (wheel-like appearance); PCR; Group A most common | NSP4 (non-structural protein 4): first viral enterotoxin described → ↑Ca2+ → Cl- secretion; also destroys villous enterocytes → malabsorption; VP4 and VP7 (outer capsid proteins - neutralizing antigens, vaccine targets) | Acute watery diarrhea in children 6 months-2 years (post-weaning); preceded by vomiting; fever; rotavirus antigen in stool; leading cause of diarrhea death in children worldwide; Rotarix/RotaTeq vaccines |
| Virus | Disease | Culture/Lab | Pathogenesis | Clinical Features |
|---|---|---|---|---|
| Rubella virus | Rubella (German measles), Congenital rubella syndrome (CRS) | Vero, RK13 cells; Viral interference (does not produce CPE itself - detected by interference with ECHO virus); Serology: IgM (acute), IgG (past/immune); PCR | Droplet transmission; infects respiratory epithelium → viremia → skin; Congenital: virus inhibits cellular mitosis in developing fetal organs → organogenesis disruption | Rubella: mild maculopapular rash (face → trunk → extremities, all at same stage), postauricular/suboccipital lymphadenopathy (Lindenberg nodes), polyarthralgia; CRS: "blueberry muffin" rash, PDA/pulmonary artery stenosis, cataracts, sensorineural deafness, microcephaly, "salt-and-pepper" retinopathy (most common clinical triad: cardiac defects + cataracts + deafness); rubella encephalitis |
| Dengue virus (DENV 1-4) | Dengue fever, Dengue hemorrhagic fever (DHF), Dengue shock syndrome (DSS) | C6/36 (Aedes cells); Vero cells; NS1 antigen detection (rapid, early); Serology (IgM/IgG ELISA); RT-PCR (early viremia) | Aedes aegypti mosquito vector; infects monocytes/macrophages via FcγR (antibody-dependent enhancement on 2nd infection with different serotype = DHF); NS1 protein (complement activation); cytokine storm | Classic dengue: "breakbone fever" (severe myalgia/arthralgia/headache/retro-orbital pain), maculopapular rash, leukopenia, thrombocytopenia, "tourniquet test" +ve; DHF: plasma leakage → hemoconcentration, pleural effusion, ascites; DSS: hypotensive shock; Warning signs: abdominal pain, persistent vomiting, mucosal bleed |
| Yellow fever virus | Yellow fever (hepatic, hemorrhagic, renal disease) | Vero cells; Serology (Plaque reduction neutralization - PRNT); IHC on liver biopsy | Aedes mosquito vector (urban) / Haemagogus (jungle); hepatitis (Councilman bodies = acidophilic hepatocyte degeneration, mid-zonal necrosis); renal tubular necrosis; hemorrhagic fever | Biphasic: Stage of infection (fever, headache, myalgia, vomiting) → brief remission → Stage of intoxication (jaundice + hemorrhage + renal failure + "black vomit"); Faget sign (relative bradycardia with fever); 20-50% mortality in toxic phase; 17D live attenuated vaccine |
| Zika virus | Zika fever, congenital Zika syndrome, Guillain-Barre | Vero cells; RT-PCR (blood/urine/semen early); Serology (cross-reacts with dengue - PRNT needed) | Aedes mosquito; sexual transmission possible; infects neural progenitor cells (cortical) → microcephaly; ADE; neonatal CNS destruction | Mild fever, rash, conjunctivitis, arthralgia (mild, self-limiting); Congenital: microcephaly (most severe), calcifications (subcortical, not periventricular), simplified cortical gyri, arthrogryposis, ocular abnormalities; GBS (post-infectious) |
| West Nile virus | West Nile fever, West Nile encephalitis/meningitis, West Nile poliomyelitis (flaccid paralysis) | Vero cells; IgM capture ELISA of serum and CSF (IgM in CSF = CNS disease); RT-PCR | Culex mosquito vector; bird reservoir; infects neurons directly | Most asymptomatic; West Nile fever (flu-like, maculopapular rash); Neuroinvasive disease (1%): meningitis, encephalitis, acute flaccid paralysis (anterior horn); tremor, Parkinsonism |
| Hepatitis C virus (HCV) | Acute hepatitis C (mostly aymptomatic), chronic hepatitis C, cirrhosis, HCC, cryoglobulinemia, lymphoma | Huh-7 cells (cell culture); HCV RNA by RT-PCR (viral load, genotyping); Anti-HCV antibody (ELISA screening); core antigen; liver biopsy (Knodell score) | Positive-sense ssRNA; HCV polyprotein cleavage; NS3/4A (protease - target of boceprevir, telaprevir, glecaprevir, grazoprevir); NS5A (target of daclatasvir, ledipasvir, velpatasvir); NS5B (RdRp - target of sofosbuvir, ribavirin); RNA polymerase lacks proofreading → quasispecies | 75-85% develop chronic hepatitis; cirrhosis (20-30% over 20-30 years) → HCC; extrahepatic: mixed cryoglobulinemia (type II - purpura + arthralgia + membranoproliferative GN), B-cell NHL; treatment: DAA (direct-acting antivirals) - pangenotypic regimens (sofosbuvir/velpatasvir) - cure rate >95% |
| Japanese Encephalitis virus (JEV) | Japanese encephalitis | Vero cells; IgM capture ELISA (CSF); RT-PCR | Culex tritaeniorhynchus mosquito; pig/ardeid bird reservoir; infects neurons; complement activation | Encephalitis (most common arboviral encephalitis worldwide); Parkinson-like features (substantia nigra involvement); bilateral thalamic lesions on MRI; Parkinsonian features, altered behavior; vaccine available |
| Virus | Disease | Culture/Lab | Pathogenesis | Clinical Features |
|---|---|---|---|---|
| Influenza A/B/C | Influenza (flu), pneumonia, pandemic influenza | Embryonated eggs, MDCK cells; Hemagglutination inhibition (HI test - gold standard serology); Rapid antigen detection (NP antigen - low sensitivity); RT-PCR (most sensitive); Viral culture; FICA | Hemagglutinin (HA - attaches to sialic acid; target of neutralizing Abs; sialic acid α2,3 - birds; α2,6 - humans; α2,3 AND α2,6 - pigs); Neuraminidase (NA - cleaves sialic acid, releases progeny virions; target of oseltamivir/zanamivir); M2 (proton channel - target of amantadine/rimantadine); Antigenic drift (gradual HA/NA mutation - annual epidemic); Antigenic shift (sudden HA/NA reassortment - pandemic, Influenza A only) | Flu: abrupt onset fever + myalgia + headache + dry cough; rapid fatigue; Complications: primary viral pneumonia (hemorrhagic), secondary bacterial (S. aureus, S. pneumoniae, H. influenzae); Reye syndrome (aspirin + influenza B in children); pandemic strains (1918 H1N1, 1957 H2N2, 1968 H3N2, 2009 H1N1) |
| Virus | Disease | Culture/Lab | Pathogenesis | Clinical Features |
|---|---|---|---|---|
| Measles (Rubeola) virus | Measles, SSPE (subacute sclerosing panencephalitis), giant cell pneumonia | Vero cells, primary monkey kidney; Multinucleated giant cells (Warthin-Finkeldey giant cells in lymphoid tissue, Hecht's pneumonia giant cells); Koplik spots (pathognomonic); Serology IgM/IgG; PCR | F (fusion) and H (hemagglutinin) proteins; receptor: CD46 (vaccine strain), CD150/SLAM (wild-type - macrophages, T/B cells), Nectin-4 (epithelial - respiratory shedding); causes transient immune suppression (measles immune amnesia - loss of pre-existing humoral immunity) | Prodrome (3 C's: Coryza, Cough, Conjunctivitis); Koplik spots (white spots on buccal mucosa opposite molars - pathognomonic, appear before rash); maculopapular rash (head → down); Complications: croup, pneumonia (Hecht), encephalitis (early), SSPE (years later - defective measles virus, progressive dementia, myoclonus, death) |
| Mumps virus | Mumps, orchitis, aseptic meningitis, pancreatitis, sensorineural hearing loss | Vero, primary monkey kidney; Hemagglutination; Serology (anti-S and anti-V antibodies); PCR (saliva, urine, CSF) | SH protein blocks TNF-α-mediated apoptosis; HN protein (hemagglutinin-neuraminidase) attaches; F protein fuses; tropism: salivary glands, testes, meninges, pancreas | Parotitis (tender swelling, "chipmunk face"); Orchitis (post-pubertal males, 20-30% - can cause infertility if bilateral); Aseptic meningitis (most common complication); Oophoritis; Pancreatitis; Sensorineural deafness (most common cause acquired SNHL) |
| RSV (Respiratory Syncytial Virus) | Bronchiolitis (#1 cause in infants), pneumonia, croup | Hep-2, Vero cells (syncytia formation); Rapid antigen DFA (nasal wash); RT-PCR (most sensitive); Serology | G protein (attachment to heparan sulfate proteoglycans); F protein (fusion, syncytia formation, target of palivizumab/nirsevimab); 2 subtypes (A,B); evades interferon response via NS1/NS2 | Bronchiolitis in infants <1yr: wheezing, tachypnea, hyperinflation, subcostal retractions; severe in premature infants, BPD, CHD, immunodeficient; Palivizumab prophylaxis (anti-F monoclonal Ab) for high-risk infants; Nirsevimab (long-acting) approved for all infants |
| Parainfluenza virus (1-4) | Croup (laryngotracheobronchitis - PIV1,2), bronchiolitis, pneumonia (PIV3) | Vero, LLC-MK2 cells; Hemagglutination; RT-PCR | HN (hemagglutinin-neuraminidase) and F proteins; | Croup (PIV1 most common): barking seal-like cough, inspiratory stridor, "steeple sign" on AP neck X-ray; worse at night; PIV3: bronchiolitis and pneumonia in infants |
| Virus | Disease | Culture/Lab | Pathogenesis | Clinical Features |
|---|---|---|---|---|
| Rabies virus | Rabies (invariably fatal once symptomatic) | BSL-2; Mouse inoculation; DFA of brain tissue (Negri bodies location); direct fluorescent antibody (DFA) on skin biopsy/brain - gold standard; PCR; Serological test (RFFIT); Sellers stain (Negri bodies - eosinophilic intracytoplasmic inclusions in Purkinje cells/hippocampal cells) | Bullet-shaped rhabdovirus; G protein (binds nAchR, NCAM, p75NTR at NMJ); retrograde axonal transport to CNS → replication in neurons → Negri body formation; anterograde spread to salivary glands; encephalitis | Long incubation (usually 1-3 months, up to years); Prodrome: pain/paresthesia at bite site, fever, agitation; Encephalitic (furious) rabies: hydrophobia (spasm on swallowing water), aerophobia, hypersalivation, hallucinations; Paralytic (dumb) rabies: ascending flaccid paralysis; nearly 100% fatal once symptomatic |
| Ebola/Marburg virus | Ebola hemorrhagic fever, Marburg hemorrhagic fever | BSL-4; RT-PCR (most sensitive, gold standard); Antigen detection; Electron microscopy (filamentous "shepherd's crook" virions) | GP (glycoprotein - target cell entry, immune evasion, shedding); VP24/VP35 (block IFN signaling); infects monocytes/macrophages, DCs, hepatocytes, adrenal cortex; cytokine storm; massive viremia; virus in all body fluids | Abrupt fever → abdominal pain, vomiting → hemorrhagic phase (petechiae, mucosal bleeding, bloody diarrhea, "black vomit") → shock/multi-organ failure; CFR 25-90% (Ebola); ZMapp, Inmazeb (mAb therapy); fruit bat reservoir |
| Virus | Disease | Culture/Lab | Pathogenesis | Clinical Features |
|---|---|---|---|---|
| HIV-1/HIV-2 | AIDS (Acquired Immunodeficiency Syndrome), HIV-associated neurocognitive disorder (HAND) | PHA-stimulated PBMCs (culture); 4th generation Ag/Ab ELISA (p24 Ag + anti-HIV Ab - screening); Western blot (confirmation, replaced by differentiation immunoassay); HIV RNA viral load (RT-PCR - monitoring); CD4+ T cell count; drug resistance testing (genotype/phenotype) | gp120 binds CD4 → conformational change → binds CCR5 (macrophage-tropic, R5) or CXCR4 (T-tropic, X4) → gp41 membrane fusion; reverse transcriptase (RNA → DNA, no proofreading → high mutation rate); integrase (integrates provirus into host genome); protease (cleaves Gag-Pol polyprotein); long-lived latent reservoirs (resting CD4+ T cells) | Acute HIV (Fiebig I-V): mononucleosis-like illness (fever, sore throat, lymphadenopathy, rash, myalgia) 2-4 weeks post-exposure; Clinical latency (years); AIDS (CD4 <200 or AIDS-defining illness): OIs (PCP, MAC, CMV retinitis, toxoplasmosis, cryptococcal meningitis), AIDS-defining cancers (Kaposi sarcoma, CNS lymphoma, invasive cervical carcinoma); wasting syndrome; HAND |
| HTLV-1 | Adult T-cell leukemia/lymphoma (ATL), HTLV-1-associated myelopathy (HAM/tropical spastic paraparesis), uveitis, infective dermatitis | PBMCs; PCR; ELISA (serology); flow cytometry (CD4+CD25+ "flower cells" in blood smear) | Tax protein (transactivates viral LTR + NF-κB → T-cell proliferation → leukemia); HBZ protein (sustains transformed state); infects CD4+ T cells; tropism to CNS (HAM); immortalization of T cells | ATL: aggressive T-cell leukemia (CD4+CD25+, "flower cells" in peripheral blood), hypercalcemia, lytic bone lesions, skin lesions; HAM: progressive spastic paraparesis (bilateral), bladder dysfunction, sensory disturbance; endemic in Japan, Caribbean, Africa, South America |
| Virus | Transmission | Chronicity | Vaccine | Serological Markers | Special |
|---|---|---|---|---|---|
| HAV | Fecal-oral | No | Yes (inactivated) | Anti-HAV IgM (acute), IgG (immune) | Shellfish, travel |
| HBV | Parenteral, sexual, vertical | Yes (5-10% adults, 90% neonates) | Yes (recombinant HBsAg) | HBsAg, HBeAg, HBV DNA, anti-HBc IgM | HCC risk; NRTI therapy |
| HCV | Parenteral (mainly IVDU) | Yes (75-85%) | No | Anti-HCV, HCV RNA, genotype | Curable with DAAs; cryoglobulinemia |
| HDV | Parenteral (co-infection or superinfection with HBV only) | Yes (superinfection >80%) | HBV vaccine protects | HBsAg (required), anti-HDV, HDV RNA | Most severe combined HBV+HDV; defective virus needs HBV |
| HEV | Fecal-oral | No (except in immunocompromised - genotype 3) | Yes (HEV 239 - approved in China) | Anti-HEV IgM/IgG, HEV RNA | Fulminant in pregnancy (30% mortality); zoonotic genotypes 3/4 (pigs) |
| Virus | Disease | Culture/Lab | Pathogenesis | Clinical Features |
|---|---|---|---|---|
| Coronaviruses (SARS-CoV-2/COVID-19) | COVID-19, SARS, MERS | Vero E6, Calu-3 cells; RT-PCR (NP/OP swab - gold standard); Rapid antigen (lower sensitivity); serology (anti-S, anti-N); BAL/saliva | Spike protein binds ACE-2 receptor (upper/lower respiratory, endothelium, kidney, gut); TMPRSS2 serine protease primes S protein for fusion; NSP3 (papain-like protease), NSP5 (main protease/3CL - target of nirmatrelvir/Paxlovid); ORF8 (immune evasion); cytokine storm; endothelial injury | COVID-19: fever, dry cough, anosmia/dysgeusia (distinctive), dyspnea, fatigue; severe: bilateral pneumonia, ARDS, cytokine release syndrome, coagulopathy; Long COVID: fatigue, brain fog, dyspnea >12 weeks; SARS-CoV-2 variant evolution (Alpha, Delta, Omicron) |
| Hantavirus | Hantavirus pulmonary syndrome (HPS), Hemorrhagic fever with renal syndrome (HFRS) | BSL-3; RT-PCR; IgM serology; Vero-E6 cells | Sin Nombre virus (HPS) - Peromyscus maniculatus (deer mouse); Hantaan (HFRS) - Apodemus mouse; Inhaled infected rodent excreta; infects pulmonary capillary endothelium (HPS) or renal endothelium (HFRS) | HPS: prodromal flu-like illness → rapidly progressive pulmonary edema + cardiogenic shock (50-70% CFR); HFRS: renal failure, hemorrhage, thrombocytopenia; Sin Nombre (SW USA) |
| Lassa fever virus | Lassa fever (hemorrhagic fever) | BSL-4; RT-PCR; Antigen detection; Serology | Mastomys natalensis (multimammate rat) reservoir; GP2 binds alpha-DG (alpha-dystroglycan); infects macrophages, dendritic cells; immunosuppression | Gradual onset fever, pharyngitis, face/neck edema, deafness (10-30% survivors); hemorrhagic manifestations; CFR 15-25% in hospitalized; Ribavirin treatment; West Africa endemic |
| Poliovirus | See Picornaviridae above | - | - | - |
| Mumps, Measles, Rubella | See Paramyxoviridae/Togaviridae above | - | - | - |
| Medium | Organisms Grown |
|---|---|
| Blood agar | Most bacteria (base medium) |
| Chocolate agar | N. gonorrhoeae, N. meningitidis, H. influenzae |
| Thayer-Martin (VCN) | Neisseria spp. (selective) |
| MacConkey agar | Gram-negative rods (lactose fermenters: pink; non-fermenters: colorless) |
| EMB (Eosin Methylene Blue) | E. coli (metallic green sheen), Enterobacteriaceae |
| XLD agar | Salmonella (red + black center), Shigella (red, no black) |
| Selenite F / GN broth | Salmonella enrichment |
| TCBS agar | Vibrio (V. cholerae = yellow; V. parahemolyticus = green) |
| BCYE agar | Legionella, Nocardia, Francisella |
| Bordet-Gengou / Regan-Lowe | Bordetella pertussis |
| Loeffler's serum slope | Corynebacterium diphtheriae (rapid) |
| Tellurite agar | C. diphtheriae (selective - black colonies) |
| LJ medium | Mycobacterium tuberculosis |
| CCFA agar | Clostridium difficile |
| Thiosulphate-Citrate-Bile-Sucrose (TCBS) | Vibrio spp. |
| Skirrow's / Campylobacter agar | Campylobacter jejuni (microaerophilic, 42°C) |
| Sabouraud's agar | Fungi |
| CIN agar | Yersinia enterocolitica (bull's eye colonies) |
| Mannitol Salt Agar (MSA) | S. aureus (yellow halo) |
| Brucella agar | Brucella spp. |
| EMJH medium | Leptospira |
| BSK medium | Borrelia burgdorferi |
| Eaton's medium | Mycoplasma pneumoniae |
| Vero / MRC-5 / HEK cells | Many viruses (HSV, CMV, Adenovirus, etc.) |
| Embryonated eggs | Influenza, Rickettsia, Rabies |
| MDCK cells | Influenza (preferred) |
Sources: Jawetz, Melnick & Adelberg's Medical Microbiology 28e; Medical Microbiology 9e (Murray); Sherris & Ryan's Medical Microbiology 8e
Generate a downloadable PDF quick reference card for board exams
mkdir -p /tmp/workspace/micro-ref-card && ls /tmp/workspace/